✦ LIBER ✦

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients

✍ Scribed by Osama Tayeh; Abdelgawaad Fahmi; Mohammed Islam; Mohamed Saied

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced flow-mediated vasodilation as a

✍ Emese Kiss; Pal Soltesz; Henrietta Der; Zsolt Kocsis; Tunde Tarr; Harjit Bhattoa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Asymmetric dimethylarginine as a risk fa

✍ Ippei Kanazawa; Shozo Yano; Yoshitomo Notsu; Toru Yamaguchi; Toru Nabika; Toshit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Elevated Plasma Asymmetric Dimethylargin

✍ Tarnow, L.; Hovind, P.; Teerlink, T.; Stehouwer, C. D.A.; Parving, H.-H. 📂 Article 📅 2004 🏛 American Diabetes Association 🌐 English ⚖ 111 KB

Asymmetric dimethylarginine (ADMA) as a

✍ Rainer H. Böger; Renke Maas; Friedrich Schulze; Edzard Schwedhelm 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Asymmetric dimethylarginine as a risk ma

✍ Sopanahalli N. Mamatha; Dindagur Nagaraja; Mariamma Philip; Rita Christopher 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Asymmetric dimethylarginine as an indepe

✍ R. H. Böger; H. G. Endres; E. Schwedhelm; H. Darius; D. Atzler; N. Lüneburg; B. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB